Azor and Pravachol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Pravachol (pravastatin sodium). Common drug interactions include cardio-respiratory arrest among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Azor and Pravachol. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Pravachol?

Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 24,382 Pravachol users. Check the latest studies of Pravachol.



On Jul, 13, 2026

14 people who take Azor and Pravachol together, and have interactions are studied.

Azor and Pravachol drug interactions.

What are the common drug interactions of Azor and Pravachol, by gender? *:

female:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Abdominal pain
  3. Cardiac failure congestive
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Dehydration (dryness resulting from the removal of water)
  6. Device dislocation
  7. Diarrhoea
  8. Drug ineffective
  9. Dysmenorrhoea (painful menstruation)
  10. Flushing (the warm, red condition of human skin)

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Cataract (clouding of the lens inside the eye)
  4. Clavicle fracture
  5. Facial bones fracture (bone fracture of face)
  6. Fall
  7. Plasma cell myeloma (cancer that begins in plasma cells)
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Urinary retention (the inability to completely or partially empty the bladder)

What are the common drug interactions of Azor and Pravachol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Device dislocation
  2. Dysmenorrhoea (painful menstruation)
  3. Injury
  4. Pelvic pain

50-59:

n/a

60+:

  1. Chronic kidney disease
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Diarrhoea
  4. Drug ineffective
  5. Facial bones fracture (bone fracture of face)
  6. Fall
  7. Hepatic enzyme increased
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  10. Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

  1. Muscle Spasms (muscle contraction): 2 people, 14.29%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 14.29%
  3. Prostatomegaly (enlargement of the prostate): 1 person, 7.14%
  4. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 7.14%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 7.14%
  6. Arthropathy: 1 person, 7.14%
  7. Back Pain: 1 person, 7.14%
  8. Constipation: 1 person, 7.14%
  9. Cough: 1 person, 7.14%
  10. Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Pravachol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Azor and Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Azor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pravachol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate; olmesartan medoxomil and pravastatin sodium (the active ingredients of Azor and Pravachol, respectively), and Azor and Pravachol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: